Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Past, Present, and Future of Nicotine Addiction Therapy.

Literature DB >> 26332005

The Past, Present, and Future of Nicotine Addiction Therapy.

Abstract

The tobacco addiction treatment field is progressing through innovations in medication development, a focus on precision medicine, and application of new technologies for delivering support in real time and over time. This article reviews the evidence for combined and extended cessation pharmacotherapy and behavioral strategies including provider advice, individual counseling, group programs, the national quitline, websites and social media, and incentives. Healthcare policies are changing to offer cessation treatment to the broad population of smokers. With knowledge of the past and present, this review anticipates what is likely on the horizon in the clinical and public health effort to address tobacco addiction.

Entities: Chemical Disease Gene Species

Keywords: cessation; cigarette; quitline; smoking; tobacco; vape

Mesh：

Substances：

Year: 2015 PMID： 26332005 PMCID： PMC5117107 DOI： 10.1146/annurev-med-111314-033712

Source DB: PubMed Journal: Annu Rev Med ISSN： 0066-4219 Impact factor: 13.739

84 in total

Review 1. Individual behavioural counselling for smoking cessation.

Authors: T Lancaster; L F Stead
Journal: Cochrane Database Syst Rev Date: 2005-04-18

Review 2. Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis.

Authors: Sonal Singh; Yoon K Loke; John G Spangler; Curt D Furberg
Journal: CMAJ Date: 2011-07-04 Impact factor: 8.262

Review 3. Is clonidine an effective smoking cessation therapy?

Authors: S G Gourlay; N L Benowitz
Journal: Drugs Date: 1995-08 Impact factor: 9.546

Review 4. Nicotine receptor partial agonists for smoking cessation.

Authors: Kate Cahill; Lindsay F Stead; Tim Lancaster
Journal: Cochrane Database Syst Rev Date: 2012-04-18

5. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.

Authors: Jill M Williams; Robert M Anthenelli; Chad D Morris; Joan Treadow; John R Thompson; Carla Yunis; Tony P George
Journal: J Clin Psychiatry Date: 2012-05 Impact factor: 4.384

6. Randomized controlled trial of a social support ('buddy') intervention for smoking cessation.

Authors: Sylvia May; Robert West; Peter Hajek; Andy McEwen; Hayden McRobbie
Journal: Patient Educ Couns Date: 2006-04-17

7. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial.

Authors: Robert M Anthenelli; Chad Morris; Tanya S Ramey; Sarah J Dubrava; Kostas Tsilkos; Cristina Russ; Carla Yunis
Journal: Ann Intern Med Date: 2013-09-17 Impact factor: 25.391

8. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes.

Authors: Maciej Lukasz Goniewicz; Jakub Knysak; Michal Gawron; Leon Kosmider; Andrzej Sobczak; Jolanta Kurek; Adam Prokopowicz; Magdalena Jablonska-Czapla; Czeslawa Rosik-Dulewska; Christopher Havel; Peyton Jacob; Neal Benowitz
Journal: Tob Control Date: 2013-03-06 Impact factor: 7.552

Review 9. Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature.

Authors: Matthew J Carpenter; Bianca F Jardin; Jessica L Burris; Amanda R Mathew; Robert A Schnoll; Nancy A Rigotti; K Michael Cummings
Journal: Drugs Date: 2013-04 Impact factor: 9.546

10. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study.

Authors: Pasquale Caponnetto; Davide Campagna; Fabio Cibella; Jaymin B Morjaria; Massimo Caruso; Cristina Russo; Riccardo Polosa
Journal: PLoS One Date: 2013-06-24 Impact factor: 3.240

38 in total

1. Chronic E-Cigarette Use Increases Neutrophil Elastase and Matrix Metalloprotease Levels in the Lung.

Authors: Arunava Ghosh; Raymond D Coakley; Andrew J Ghio; Marianne S Muhlebach; Charles R Esther; Neil E Alexis; Robert Tarran
Journal: Am J Respir Crit Care Med Date: 2019-12-01 Impact factor: 21.405

2. Associations between e-cigarette and combustible cigarette use among U.S. cancer survivors: implications for research and practice.

Authors: Godfred O Antwi; David K Lohrmann; Wasantha Jayawardene; Angela Chow; Cecilia S Obeng; Aaron M Sayegh
Journal: J Cancer Surviv Date: 2019-04-06 Impact factor: 4.442

Review 3. Managing smoking cessation.

Authors: Robert D Reid; Gillian Pritchard; Kathryn Walker; Debbie Aitken; Kerri-Anne Mullen; Andrew L Pipe
Journal: CMAJ Date: 2016-10-03 Impact factor: 8.262

4. Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction.

Authors: Zongmin Zhao; Brian Harris; Yun Hu; Theresa Harmon; Paul R Pentel; Marion Ehrich; Chenming Zhang
Journal: Biomaterials Date: 2017-11-20 Impact factor: 12.479

Review 5. Tobacco Cessation in Oncology Care.

Authors: Emily G Kaiser; Judith J Prochaska; Matthew S Kendra
Journal: Oncology Date: 2018-06-19 Impact factor: 2.935

6. Rationalization of a nanoparticle-based nicotine nanovaccine as an effective next-generation nicotine vaccine: A focus on hapten localization.

Authors: Zongmin Zhao; Yun Hu; Theresa Harmon; Paul Pentel; Marion Ehrich; Chenming Zhang
Journal: Biomaterials Date: 2017-05-19 Impact factor: 12.479

7. Pharmacogenomics of Nicotine Metabolism: Novel CYP2A6 and CYP2B6 Genetic Variation Patterns in Alaska Native and American Indian Populations.

Authors: Katrina G Claw; Julie A Beans; Seung-Been Lee; Jaedon P Avey; Patricia A Stapleton; Steven E Scherer; Ahmed El-Boraie; Rachel F Tyndale; Deborah A Nickerson; Denise A Dillard; Kenneth E Thummel; Renee F Robinson
Journal: Nicotine Tob Res Date: 2020-05-26 Impact factor: 4.244